GM2-KLH/QS-21

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
18961
Adjuvant ganglioside GM2-KLH/QS-21 Vaccination Post-operative adjuvant ganglioside GM2-KLH/QS-21 vaccination treatment vs observation after resection of primary cutaneous melanoma (AJCC stage II, T3-T4N0M0), a 2-arm multicenter randomized phase III trial

Back to Protocol section